Quarter Financials
Vallon Pharmaceuticals, Inc. (VLON)
$0.4
-0.06 (-13.04%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Net Income | -7 | -2 | -2 | -0 | -2 | -3 | -3 | -1 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -27 | -31 | -29 | -27 | -26 | -25 | -22 | -19 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Capital Expenditure | - | - | - | - | - | - | - | - |
|---|
| Net PPE | 0 | - | - | - | - | - | 0 | - |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| New Purchases | - | -1 | - | -0 | -0 | - | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|